Investigational drugs in development to prevent neuromyelitis optica relapses
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs in development to prevent neuromyelitis optica relapses
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 27, Issue 3, Pages 265-271
Publisher
Informa UK Limited
Online
2018-02-22
DOI
10.1080/13543784.2018.1443077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuromyelitis optica
- (2017) Florence Pache et al. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
- (2017) Jan-Patrick Stellmann et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
- (2017) Jun-ichi Kira Multiple Sclerosis Journal
- Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder
- (2017) Bassem I Yamout et al. Multiple Sclerosis Journal
- Fatigue as a symptom or comorbidity of neurological diseases
- (2017) Iris-Katharina Penner et al. Nature Reviews Neurology
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study
- (2017) Bruno Cesar Bacchiega et al. Journal of the American Heart Association
- Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
- (2017) Jun-ichi Kira Multiple Sclerosis Journal
- Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder
- (2017) Bassem I Yamout et al. Multiple Sclerosis Journal
- Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders
- (2017) Felix Schmidt et al. Multiple Sclerosis and Related Disorders
- Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community
- (2017) Stephanie Eaneff et al. Multiple Sclerosis and Related Disorders
- Interleukin-6: an emerging regulator of pathological pain
- (2016) Ya-Qun Zhou et al. Journal of Neuroinflammation
- MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
- (2016) Florence Pache et al. Journal of Neuroinflammation
- MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
- (2016) Sven Jarius et al. Journal of Neuroinflammation
- MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
- (2016) Sven Jarius et al. Journal of Neuroinflammation
- MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
- (2016) Sven Jarius et al. Journal of Neuroinflammation
- Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
- (2016) Ilya Ayzenberg et al. JOURNAL OF NEUROLOGY
- Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis
- (2016) George Tackley et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
- (2016) Patrick Waters et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status
- (2016) Yazhuo Kong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
- (2016) Nadja Borisow et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders in children and adolescents
- (2016) Silvia Tenembaum et al. NEUROLOGY
- Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders
- (2016) Valentina Damato et al. JAMA Neurology
- Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
- (2016) Nadja Borisow et al. Multiple Sclerosis Journal
- Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment
- (2016) George Tackley et al. Multiple Sclerosis and Related Disorders
- Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder
- (2016) Fumihito Yoshii et al. Multiple Sclerosis and Related Disorders
- Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica
- (2015) Tetsuya Akaishi et al. JOURNAL OF NEUROIMMUNOLOGY
- Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series
- (2015) Laura Azzopardi et al. JOURNAL OF NEUROLOGY
- Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
- (2015) Markus Krumbholz et al. JOURNAL OF NEUROLOGY
- Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
- (2015) M Radaelli et al. Multiple Sclerosis Journal
- Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
- (2015) Bruce AC Cree et al. Multiple Sclerosis Journal
- Demographic and clinical features of neuromyelitis optica: A review
- (2015) L Pandit et al. Multiple Sclerosis Journal
- Challenges and opportunities in designing clinical trials for neuromyelitis optica
- (2015) B. G. Weinshenker et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
- (2015) Ingo Kleiter et al. Neurotherapeutics
- Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
- (2015) Richard J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
- (2015) Stephane Kremer et al. JAMA Neurology
- Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
- (2015) Marius Ringelstein et al. JAMA Neurology
- Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
- (2015) M Radaelli et al. Multiple Sclerosis Journal
- Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
- (2015) Bruce AC Cree et al. Multiple Sclerosis Journal
- Demographic and clinical features of neuromyelitis optica: A review
- (2015) L Pandit et al. Multiple Sclerosis Journal
- CD19 as a molecular target in CNS autoimmunity
- (2014) Olaf Stüve et al. ACTA NEUROPATHOLOGICA
- Neuromyelitis optica: clinical features, immunopathogenesis and treatment
- (2014) S. Jarius et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Evidence for classic complement activity in neuromyelitis optica
- (2014) Melina V. Jones et al. CLINICAL NEUROPATHOLOGY
- Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab
- (2014) Joanna Kitley et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
- (2014) Liene Elsone et al. Multiple Sclerosis Journal
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies
- (2014) Joanna Kitley et al. JAMA Neurology
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Pathologic yawning in neuromyelitis optica spectrum disorders
- (2014) Marco A. Lana-Peixoto et al. Multiple Sclerosis and Related Disorders
- Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
- (2013) Corinna Trebst et al. JOURNAL OF NEUROLOGY
- Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
- (2013) J. Kitley et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Hope for a rare disease: eculizumab in neuromyelitis optica
- (2013) Friedemann Paul LANCET NEUROLOGY
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients
- (2013) L Kremer et al. Multiple Sclerosis Journal
- Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
- (2013) N Collongues et al. Multiple Sclerosis Journal
- Neuromyelitis optica
- (2013) B. Wildemann et al. NERVENARZT
- A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
- (2013) Su-Hyun Kim et al. JAMA Neurology
- Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
- (2012) Ingo Kleiter ARCHIVES OF NEUROLOGY
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
- (2012) Sven Jarius et al. Journal of Neuroinflammation
- Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
- (2012) P. Cabre et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuropathic pruritus (itch) in neuromyelitis optica
- (2012) Liene Elsone et al. Multiple Sclerosis Journal
- Thrombotic microangiopathy and associated renal disorders
- (2012) T. Barbour et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Does natalizumab therapy worsen neuromyelitis optica?
- (2012) A. Jacob et al. NEUROLOGY
- Treatment of neuromyelitis optica: Review and recommendations
- (2012) Dorlan J. Kimbrough et al. Multiple Sclerosis and Related Disorders
- Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
- (2011) Ju-Hong Min et al. Multiple Sclerosis Journal
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
- (2010) Su-Hyun Kim et al. ARCHIVES OF NEUROLOGY
- Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
- (2010) Sven Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
- Complement component 5a (C5a)
- (2009) Helga D. Manthey et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Treatment of Neuromyelitis Optica With Rituximab
- (2008) ARCHIVES OF NEUROLOGY
- Neuromyelitis optica pathogenesis and aquaporin 4
- (2008) David J Graber et al. Journal of Neuroinflammation
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search